Medical expert of the article
New publications
Treatment of plague
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Etiotropic treatment of plague should be started if there is a suspicion of this disease, without waiting for bacteriological confirmation of the diagnosis. It includes the use of antibacterial drugs. When studying natural strains of plague bacteria on the territory of Russia, resistance to common antimicrobial agents was not detected. Etiotropic treatment of plague is carried out according to the approved schemes.
Scheme of antibacterial drugs in the treatment of bubonic plague form
A drug |
Mode of application |
Single dose, g |
Multiplicity of application per day |
Duration of the course, day |
Doxycycline |
Inside |
0.2 |
2 |
10 |
Ciprofloxacin |
Inside |
0.5 |
2 |
7-10 |
Pefloxacin |
Inside |
0.4 |
2 |
7-10 |
Ofloxacin |
Inside |
0.4 |
2 |
7-10 |
Gentamicin |
In / m |
0.16 |
3 |
7th |
Amikacin |
In / m |
0.5 |
2 |
7th |
Streptomycin |
In, m |
0.5 |
2 |
7th |
Tobramycin |
In / m |
01 |
2 |
7th |
Ceftriaxone |
In / m |
2 |
1 |
7th |
Cefotaxime |
In / m |
2 |
3-4 |
7-10 |
Ceftazidime |
In / m |
2 |
2 |
7-10 |
Ampicillin / Sulbactam |
In / m |
2.1 |
3 |
7-10 |
Azrethon |
In / m |
2 |
3 |
7-10 |
Scheme of antibacterial drugs in the treatment of pulmonary and septic forms of the plague
A drug |
Mode of application |
Single dose, g |
Multiplicity of application per day |
Duration of the course, day |
Ciprofloxacin |
Inside |
0 75 |
2 |
10-14 |
Pefloxacin |
Inside |
0.8 |
2 |
10-14 |
Ofloxacin |
Inside |
0.4 |
2 |
10-14 |
Doxycycline |
Inside |
0.2 on the 1st reception, then on 0.1 |
2 |
10-14 |
Gentamicin |
In / m |
0 16 |
3 |
10 |
Amikacin |
In / m |
05 |
3 |
10 |
Streptomycin |
In / m |
0.5 |
3 |
10 |
Ciprofloxacin |
In / in |
0.2 |
2 |
7th |
Cefotaxime |
V / m, in / in |
3 |
3 |
10 |
Ceftazidime |
V / m, in / in |
2 |
3 |
10 |
Chloramphenicol (levomycetin sodium succinate) |
V / m, in / in |
25-35 mg / kg |
3 |
7th |
Ceftriaxone |
In / m. In / in |
2 |
2 |
7-10 |
Schemes of application of combinations of antibacterial drugs in the treatment of pulmonary and septic forms of plague
A drug |
Mode of application |
Single dose, g |
Multiplicity of application per day |
Duration of the course, day |
Ceftriaxone - streptomycin (or amikacin) |
V / m, in / in |
1-0 5 |
2 |
10 |
Ceftriaxone gentamicin |
V / m, in / in |
1 + 0.08 |
2 |
10 |
Ceftriaxone - rifampicin |
In / in, inside |
1-0.3 |
2 |
10 |
Ciprofloxacin-rifampicin |
Inside |
0.5 + 0.3 |
2 |
10 |
Ciprofloxacin + streptomycin (or amikacin) |
Inside, in / in, in / m |
0.5-0.5 |
2 |
10 |
Ciprofloxacin + gentamicin |
Inside, in / in, in / m, |
0.5 + 0.08 |
2 |
10 |
Ciprofloxacin-ceftriaxone |
In / in, in / m |
0 1-0.2-1-1 |
2 |
10 |
Rifampicin and gentamicin |
Inside, in / in, in / m |
0.3-0.08 |
2 |
Yu |
Rifampicin - streptomycin (or amikacin) |
Inside, in / in, in / m |
0.3-0.5 |
2 |
10 |
In severe cases, the use during the first four days of the disease of compatible combinations of antibacterial agents in the doses indicated in the schemes is recommended. In the following days, the treatment is continued with a single drug. The first 2-3 days of the drug are injected parenterally, and then switch to oral administration.
Along with the specific pathogenic treatment of plague, aimed at combating acidosis, cardiovascular insufficiency and respiratory failure, microcirculation disorders, edema of the brain, hemorrhagic syndrome. Disintoxication therapy consists of intravenous infusions of colloid (reopolyglucin, plasma) and crystalloid solutions (glucose 5-10%, polyionic solutions) to 40-50 ml / kg per day. The anti-plague serum used earlier, specific gamma-globulin in the course of observation proved to be ineffective, and at present they are not used in practice, nor do they use the plague bacteriophage. Patients are discharged after complete recovery (with bubonic form not earlier than the 4th week, with pulmonary form - not earlier than the 6th week from the day of clinical recovery) and a triple negative result obtained after sowing the bubble, sputum or blood, th, 4 th, 6 th days after the cessation of treatment. After discharge, medical supervision is carried out for 3 months.